Indication
Acute exacerbation of multiple sclerosis
An acute exacerbation of multiple sclerosis—also termed a relapse, attack, or flare—is a sudden clinical worsening characterized by the emergence of new neurological symptoms or the intensification of preexisting deficits lasting at least 24 hours in the absence of fever, infection, or metabolic disturbance. Read more about Acute exacerbation of multiple sclerosis
324 drugs 162 manufacturers
Drugs that treat it
Common Acute exacerbation of multiple sclerosis therapies.
PREDNISONE
HYDROCORTISONE
METHYLPREDNISOLONE
PREDNISOLONE
KHINDIVI (hydrocortisone)
PREDNISOLONE SODIUM PHOS ODT (prednisolone sodium phosphate)
DEXAMETHASONE
DEXAMETHASONE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAn acute exacerbation of multiple sclerosis—also termed a relapse, attack, or flare—is a sudden clinical worsening characterized by the emergence of new neurological symptoms or the intensification of preexisting deficits lasting at least 24 hours in the absence of fever, infection, or metabolic disturbance.
This acute state primarily affects adults and youth living with relapsing forms of multiple sclerosis, involving inflammatory damage to the central nervous system.
Pathophysiologically, it is driven by focal, immune-mediated breakdown of the blood-brain barrier resulting in perivascular infiltration of lymphocytes, acute demyelination, and axonal injury within the brain, optic nerves, or spinal cord.
Patients commonly present with acute unilateral optic neuritis, focal motor weakness, sensory disturbances, ataxia, or bowel and bladder dysfunction.
- nih.gov
An acute exacerbation of multiple sclerosis—also termed a relapse, attack, or flare—is a sudden clinical worsening characterized by the emergence of new neurological symptoms or the intensification of preexisting deficits lasting at least 24 hours in the absence of fever, infection, or metabolic disturbance
- nationalmssociety.org
An acute exacerbation of multiple sclerosis—also termed a relapse, attack, or flare—is a sudden clinical worsening characterized by the emergence of new neurological symptoms or the intensification of preexisting deficits lasting at least 24 hours in the absence of fever, infection, or metabolic disturbance
- nih.gov
This acute state primarily affects adults and youth living with relapsing forms of multiple sclerosis, involving inflammatory damage to the central nervous system Pathophysiologically, it is driven by focal, immune-mediated breakdown of the blood-brain barrier resulting in perivascular infiltration of lymphocytes, acute demyelination, and axonal injury within the brain, optic nerves, or spinal cord Patients commonly present with acute unilateral optic neuritis, focal motor weakness, sensory dist...
- fda.gov
This acute state primarily affects adults and youth living with relapsing forms of multiple sclerosis, involving inflammatory damage to the central nervous system
- nih.gov
Pathophysiologically, it is driven by focal, immune-mediated breakdown of the blood-brain barrier resulting in perivascular infiltration of lymphocytes, acute demyelination, and axonal injury within the brain, optic nerves, or spinal cord
Personalize your experience
Follow Acute exacerbation of multiple sclerosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.